본문 바로가기
KERD
논문KCI 등재

Application of photodynamic therapy in gastrointestinal disorders: an outdated or re-emerging technique?

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류내과학

초록

Photodynamic therapy (PDT) is a promising therapeutic modality that involves the administration of a photosensitizer followed by local illumination with a specific wavelength of light in the presence of oxygen. PDT is minimally invasive, has high selectivity for cancer, and has good patient compliance due to the simplicity of the procedure; therefore, PDT is widely used as a palliative and salvage treatment in patients with various gastrointestinal malignancies. When used as a salvage treatment for locoregional failures after definitive chemoradiotherapy for esophageal cancer, favorable results have been reported. PDT in conjunction with biliary stenting is a promising palliative treatment for unresectable cholangiocarcinoma, and can be used as an advanced diagnostic and therapeutic strategy in peritoneal dissemination of gastric cancer. Recent clinical reports of PDT for treating non-resectable pancreatic cancer also show promising results. To widen the application of PDT, the integration of PDT with molecular imaging and nanotechnology is being extensively studied. Based on these new developments, PDT is likely to re-emerge as a valuable technique in the treatment of diverse gastrointestinal diseases.

Abstract

Photodynamic therapy (PDT) is a promising therapeutic modality that involves the administration of a photosensitizer followed by local illumination with a specific wavelength of light in the presence of oxygen. PDT is minimally invasive, has high selectivity for cancer, and has good patient compliance due to the simplicity of the procedure; therefore, PDT is widely used as a palliative and salvage treatment in patients with various gastrointestinal malignancies. When used as a salvage treatment for locoregional failures after definitive chemoradiotherapy for esophageal cancer, favorable results have been reported. PDT in conjunction with biliary stenting is a promising palliative treatment for unresectable cholangiocarcinoma, and can be used as an advanced diagnostic and therapeutic strategy in peritoneal dissemination of gastric cancer. Recent clinical reports of PDT for treating non-resectable pancreatic cancer also show promising results. To widen the application of PDT, the integration of PDT with molecular imaging and nanotechnology is being extensively studied. Based on these new developments, PDT is likely to re-emerge as a valuable technique in the treatment of diverse gastrointestinal diseases.

참고문헌 (55)

  1. McCaughan JS Jr, "Hematoporphyrin-derivative and photoradiation therapy of malignant tumors", Lasers Surg Med, 3, pp.199~209 (1983)
  2. Yoshida K, "Photodynamic therapy for superficial esophageal cancer: a phase III study using PHE and excimer dye laser", Gan To Kagaku Ryoho, 20, pp.2063~2066 (1993)
  3. Soetikno R, "Endoscopic mucosal resection for early cancers of the upper gastrointestinal tract", J Clin Oncol, 23, pp.4490~4498 (2005)
  4. Dolmans DE, "Photodynamic therapy for cancer", Nat Rev Cancer, 3, pp.380~387 (2003)
  5. Barr H, "Review article: the potential role for photodynamic therapy in the management of upper gastrointestinal disease", Aliment Pharmacol Ther, 15, pp.311~321 (2001)
  6. Pogue BW, "Protoporphyrin IX fluorescence photobleaching increases with the use of fractionated irradiation in the esophagus", J Biomed Opt, 13, pp.034009~ (2008)
  7. Laukka MA, "Initial results using low-dose photodynamic therapy in the treatment of Barrett’s esophagus", Gastrointest Endosc, 42, pp.59~63 (1995)
  8. Overholt BF, "Barrett’s esophagus: photodynamic therapy for ablation of dysplasia, reduction of specialized mucosa, and treatment of superficial esophageal cancer", Gastrointest Endosc, 42, pp.64~70 (1995)
  9. Overholt BF, "Photodynamic therapy for Barrett’s esophagus: follow-up in 100 patients", Gastrointest Endosc, 49, pp.1~7 (1999)
  10. Overholt BF, "Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett’s esophagus: international, partially blinded, randomized phase III trial", Gastrointest Endosc, 62, pp.488~498 (2005)
  11. Yano T, "Phase I study of photodynamic therapy using talaporfin sodium and diode laser for local failure after chemoradiotherapy for esophageal cancer", Radiat Oncol, 7, pp.113~ (2012)
  12. Yano T, "Long-term results of salvage photodynamic therapy for patients with local failure after chemoradiotherapy for esophageal squamous cell carcinoma", Endoscopy, 43, pp.657~663 (2011)
  13. Nakamura T, "Photodynamic therapy of superficial esophageal cancer with a transparent hood", Gastrointest Endosc, 60, pp.120~124 (2004)
  14. Tanaka T, "Photodynamic therapy for large superficial squamous cell carcinoma of the esophagus", Gastrointest Endosc, 73, pp.1~6 (2011)
  15. Yano T, "Photodynamic therapy as salvage treatment for local failures after definitive chemoradiotherapy for esophageal cancer", Gastrointest Endosc, 62, pp.31~36 (2005)
  16. Hatogai K, "Salvage photodynamic therapy for local failure after chemoradiotherapy for esophageal squamous cell carcinoma", Gastrointest Endosc, 83, pp.1130~1139 (2016)
  17. Litle VR, "Photodynamic therapy as palliation for esophageal cancer: experience in 215 patients", Ann Thorac Surg, 76, pp.1687~1692 (2003)
  18. Lindenmann J, "Individualized, multimodal palliative treatment of inoperable esophageal cancer: clinical impact of photodynamic therapy resulting in prolonged survival", Lasers Surg Med, 44, pp.189~198 (2012)
  19. 윤현영, "Role of Photodynamic Therapy in the Palliation of Obstructing Esophageal Cancer", The Korean Journal of Internal Medicine, 27(3), pp.278~284 (2012), 대한내과학회[DOI]
  20. Pennathur A, "Esophagectomy for T1 esophageal cancer: outcomes in 100 patients and implications for endoscopic therapy", Ann Thorac Surg, 87, pp.1048~1054 (2009)
  21. Tachibana M, "Clinicopathologic features of superficial esophageal cancer:results of consecutive 100 patients", Ann Surg Oncol, 15, pp.104~116 (2008)
  22. Miyata H, "Salvage esophagectomy after definitive chemoradiotherapy for thoracic esophageal cancer", J Surg Oncol, 100, pp.442~446 (2009)
  23. Heier SK, "Photodynamic therapy for obstructing esophageal cancer: light dosimetry and randomized comparison with Nd:YAG laser therapy", Gastroenterology, 109, pp.63~72 (1995)
  24. Lightdale CJ, "Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial", Gastrointest Endosc, 42, pp.507~512 (1995)
  25. Soderlund C, "Covered metal versus plastic stents for malignant common bile duct stenosis: a prospective, randomized, controlled trial", Gastrointest Endosc, 63, pp.986~995 (2006)
  26. O’Brien S, "A three year follow up of self expanding metal stents in the endoscopic palliation of longterm survivors with malignant biliary obstruction", Gut, 36, pp.618~621 (1995)
  27. Kahaleh M, "Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy", Clin Gastroenterol Hepatol, 6, pp.290~297 (2008)
  28. Ortner ME, "Successful photodynamic therapy for nonresectable cholangiocarcinoma:a randomized prospective study", Gastroenterology, 125, pp.1355~1363 (2003)
  29. Zoepf T, "Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy", Am J Gastroenterol, 100, pp.2426~2430 (2005)
  30. Witzigmann H, "Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1", r2 resection, 2006, pp.244, 230~239
  31. Quyn AJ, "Photodynamic therapy is associated with an improvement in survival in patients with irresectable hilar cholangiocarcinoma", HPB (Oxford), 11, pp.570~577 (2009)
  32. Cheon YK, "Longterm outcome of photodynamic therapy compared with biliary stenting alone in patients with advanced hilar cholangiocarcinoma", HPB (Oxford), 14, pp.185~193 (2012)
  33. Lee TY, "Photodynamic therapy prolongs metal stent patency in patients with unresectable hilar cholangiocarcinoma", World J Gastroenterol, 18, pp.5589~5594 (2012)
  34. Huggett MT, "Phase I", II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer, 2014, pp.110, 1698~1704
  35. Bown SG, "Photodynamic therapy for cancer of the pancreas", Gut, 50, pp.549~557 (2002)
  36. Kelty CJ, "The use of 5-aminolaevulinic acid as a photosensitiser in photodynamic therapy and photodiagnosis", Photochem Photobiol Sci, 1, pp.158~168 (2002)
  37. Isomoto H, "In vivo fluorescence navigation of gastric and upper gastrointestinal tumors by 5-aminolevulinic acid mediated photodynamic diagnosis with a laser-equipped video image endoscope", Photodiagnosis Photodyn Ther, 12, pp.201~208 (2015)
  38. Kishi K, "Diagnostic laparoscopy with 5-aminolevulinic-acid-mediated photodynamic diagnosis enhances the detection of peritoneal micrometastases in advanced gastric cancer", Oncology, 87, pp.257~265 (2014)
  39. Kishi K, "Staging laparoscopy using ALA-mediated photodynamic diagnosis improves the detection of peritoneal metastases in advanced gastric cancer", J Surg Oncol, 106, pp.294~298 (2012)
  40. Mari E, "Efficacy of adjuvant chemotherapy after curative resection for gastric cancer:a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell’Apparato Digerente)", Ann Oncol, 11, pp.837~843 (2000)
  41. Yan TD, "A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer", Ann Surg Oncol, 14, pp.2702~2713 (2007)
  42. Baeza MR, "Adjuvant radiochemotherapy in the treatment of completely resected, locally advanced gastric cancer", Int J Radiat Oncol Biol Phys, 50, pp.645~650 (2001)
  43. Kishi K, "Talaporfin-mediated photodynamic therapy for peritoneal metastasis of gastric cancer in an in vivo mouse model: drug distribution and efficacy studies", Int J Oncol, 36, pp.313~320 (2010)
  44. Tsujimoto H, "Photodynamic therapy using nanoparticle loaded with indocyanine green for experimental peritoneal dissemination of gastric cancer", Cancer Sci, 105, pp.1626~1630 (2014)
  45. Miller JD, "Photodynamic therapy with the phthalocyanine photosensitizer Pc 4: the case experience with preclinical mechanistic and early clinical-translational studies", Toxicol Appl Pharmacol, 224, pp.290~299 (2007)
  46. Barolet D., "Light-emitting diodes (LEDs) in dermatology", Semin Cutan Med Surg, 27, pp.227~238 (2008)
  47. Juzeniene A, "Effectiveness of different light sources for 5-aminolevulinic acid photodynamic therapy", Lasers Med Sci, 19, pp.139~149 (2004)
  48. Mang TS., "Lasers and light sources for PDT: past, present and future", Photodiagnosis Photodyn Ther, 1, pp.43~48 (2004)
  49. Henderson BW, "Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate", Cancer Res, 60, pp.525~529 (2000)
  50. Curnow A, "Oxygen monitoring during 5-aminolaevulinic acid induced photodynamic therapy in normal rat colon. Comparison of continuous and fractionated light regimes", J Photochem Photobiol B, 58, pp.149~155 (2000)
  51. Goetz M, "Molecular imaging in gastrointestinal endoscopy", Gastroenterology, 138, pp.828.e1~833.e1 (2010)
  52. Kim JH, "Targeted photodynamic therapy with colon cancer-specific peptide conjugated photosensitizer", Photodiagnosis Photodyn Ther, 12, pp.340~ (2015)
  53. Bae BC, "Polymeric photosensitizer-embedded self-expanding metal stent for repeatable endoscopic photodynamic therapy of cholangiocarcinoma", Biomaterials, 35, pp.8487~8495 (2014)
  54. Min D, "Photochemical tissue penetration via photosensitizer for effective drug penetration in a non-vascular tumor", Biomaterials, 52, pp.484~493 (2015)
  55. Spring BQ, "A photoactivable multi-inhibitor nanoliposome for tumour control and simultaneous inhibition of treatment escape pathways", Nat Nanotechnol, 11, pp.378~387 (2016)

관련 논문AI추천

이 간행물의 다른 논문 (25건)